Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 7, 2010Clinical Cancer ResearchOpen Access

Expression of p21 Protein Predicts Clinical Outcome in DLBCL Patients Older than 60 Years Treated with R-CHOP but not CHOP: A Prospective ECOG and Southwest Oncology Group Correlative Study on E4494

View Full Paper
Ask AI
Bookmark
Share

Authors

JWJane N. WinterNorthwestern UniversitySLShuli LiShandong Tumor HospitalVAVikas AuroraNorthwestern University

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Winter et al. (2010) studied this question.

synapsesocial.com/papers/6a1bd6b527b545b111a919bbhttps://doi.org/10.1158/1078-0432.ccr-09-1219
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1The proteasome inhibitor bortezomib (PS-341) inhibits growth and induces apoptosis in primary effusion lymphoma cells2005 · 72 citations
  2. 2Mutations in the DNA-binding codons of TP53, which are associated with decreased expression of TRAILreceptor-2, predict for poor survival in diffuse large B-cell lymphoma2007 · 112 citations
  3. 3Multiparameter Immunohistochemical Analysis of the Cell Cycle Proteins Cyclin D1, Ki-67, p21WAF1, p27KIP1, and p53 in Mantle Cell Lymphoma2000 · 32 citations
  4. 4Lenalidomide Monotherapy in Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma2008 · 374 citations